Phreesia, Inc. (NYSE:PHR) Receives Average Rating of “Hold” from Analysts

Phreesia, Inc. (NYSE:PHR) has been assigned a consensus rating of “Hold” from the nineteen ratings firms that are presently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and nine have assigned a buy rating to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $16.6471.

Several research analysts recently issued reports on PHR shares. Wall Street Zen raised shares of Phreesia from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. Mizuho decreased their price objective on Phreesia from $22.00 to $19.00 and set an “outperform” rating on the stock in a report on Tuesday, March 24th. Barclays reissued an “equal weight” rating and issued a $10.00 target price (down from $24.00) on shares of Phreesia in a report on Thursday, May 14th. Needham & Company LLC cut their target price on Phreesia from $35.00 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, March 31st. Finally, Wells Fargo & Company reaffirmed an “equal weight” rating and issued a $9.00 price target (down from $15.00) on shares of Phreesia in a research note on Wednesday, May 20th.

Insider Buying and Selling at Phreesia

In related news, General Counsel Allison C. Hoffman sold 14,483 shares of the stock in a transaction dated Friday, April 10th. The shares were sold at an average price of $8.07, for a total transaction of $116,877.81. Following the completion of the sale, the general counsel owned 163,485 shares in the company, valued at $1,319,323.95. This trade represents a 8.14% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider David Linetsky sold 8,332 shares of Phreesia stock in a transaction dated Friday, April 10th. The shares were sold at an average price of $8.07, for a total transaction of $67,239.24. Following the transaction, the insider directly owned 224,056 shares of the company’s stock, valued at $1,808,131.92. This represents a 3.59% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders sold 42,927 shares of company stock valued at $368,022. 5.20% of the stock is currently owned by company insiders.

Institutional Trading of Phreesia

Several large investors have recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC increased its holdings in shares of Phreesia by 1,119.8% during the first quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock worth $27,000 after buying an additional 3,001 shares in the last quarter. Van ECK Associates Corp boosted its holdings in shares of Phreesia by 78.7% in the 4th quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock worth $42,000 after acquiring an additional 1,102 shares in the last quarter. New York State Teachers Retirement System bought a new stake in Phreesia during the 1st quarter worth approximately $44,000. Rockefeller Capital Management L.P. grew its position in Phreesia by 354.6% during the 4th quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock worth $47,000 after acquiring an additional 2,149 shares during the last quarter. Finally, KBC Group NV increased its holdings in Phreesia by 83.4% during the 4th quarter. KBC Group NV now owns 3,449 shares of the company’s stock valued at $58,000 after purchasing an additional 1,568 shares in the last quarter. 92.10% of the stock is owned by institutional investors.

Phreesia Stock Up 4.3%

PHR opened at $10.73 on Thursday. The company has a market capitalization of $663.53 million, a P/E ratio of 71.57 and a beta of 0.87. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.76 and a quick ratio of 1.76. The firm’s fifty day moving average price is $9.42 and its two-hundred day moving average price is $11.82. Phreesia has a fifty-two week low of $7.77 and a fifty-two week high of $32.76.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Wednesday, May 27th. The company reported $0.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.02 by $0.03. Phreesia had a net margin of 1.85% and a return on equity of 5.13%. The company had revenue of $130.94 million during the quarter, compared to analysts’ expectations of $130.08 million. During the same quarter in the prior year, the company posted ($0.07) EPS. The business’s revenue was up 12.9% on a year-over-year basis. On average, analysts anticipate that Phreesia will post 0.35 EPS for the current year.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.